ST2 and IL‐33 polymorphisms and the development of childhood asthma: a prospective birth cohort study in Finnish children
APMIS · 2024-07 · 132 (7) · 515-525
DOI: 10.1111/apm.13411 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift APMIS, online erschienen am 02.04.2024. Verfasst von Johanna T Teräsjärvi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedicine, Research Centre for Infections and Immunity, University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Asthma, Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Allergiasäätiö, Ida Montinin Säätiö, Väinö ja Laina Kiven Säätiö.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
The ST2/IL‐33 signaling pathway has an important role in the host inflammatory response. Here we aimed to study the association of ST2 and IL‐33 polymorphisms with serum soluble (s) ST2 and IL‐33 concentrations in healthy Finnish children and, in addition, their association with childhood asthma. In total, 146 children were followed from birth to the age 7 years for the development of asthma. Single‐nucleotide polymorphisms (SNPs) in ST2 and IL‐33 were determined, and associations of the SNP variants with serum levels of sST2 and IL‐33 at age of 13 months and with recurrent wheezing and childhood asthma at 7 years of age were analyzed. Children with ST2 rs1041973 AC/AA genotypes had significantly lower level of serum sST2 (2453 pg/mL; IQR 2265) than those with CC genotype (5437 pg/mL; IQR 2575; p = < 0.0001). Similar difference was also observed with ST2 rs13408661. No differences were observed between subjects with studied IL‐33 SNPs. Children who carried genetic variants of ST2 rs1041973 or rs13408661 seemed to have a higher risk of asthma. In contrast, children who carried genetic variants of IL‐33 rs12551268 were less often diagnosed with asthma. Even though these SNPs seemed to associate with asthma, the differences were not statistically significant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedicine, Research Centre for Infections and Immunity, University of Turku, Turku, Finland.
- Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.
- InFLAMES Research Flagship Centre, University of Turku, Turku, Finland.
ORCID-Profile: Johanna T Teräsjärvi, Qiushui He
Förderung
- Allergiasäätiö
- Ida Montinin Säätiö
- Väinö ja Laina Kiven Säätiö
- Turun Yliopistosäätiö
- Hengityssairauksien Tutkimussäätiö
- Sigrid Juséliuksen Säätiö
- Tampereen Tuberkuloosisäätiö
Zitieren
APA
Teräsjärvi, J. T., Toivonen, L., Mertsola, J., Peltola, V., & He, Q. (2024). ST2 and IL‐33 polymorphisms and the development of childhood asthma: a prospective birth cohort study in Finnish children. APMIS, 132(7), 515-525. https://doi.org/10.1111/apm.13411
Vancouver
Teräsjärvi JT, Toivonen L, Mertsola J, Peltola V, He Q. ST2 and IL‐33 polymorphisms and the development of childhood asthma: a prospective birth cohort study in Finnish children. APMIS. 2024;132(7):515-525. doi:10.1111/apm.13411
BibTeX
@article{Tersjrvi2024,
author = {Teräsjärvi, Johanna T and Toivonen, Laura and Mertsola, Jussi and Peltola, Ville and He, Qiushui},
title = {ST2 and IL‐33 polymorphisms and the development of childhood asthma: a prospective birth cohort study in Finnish children},
journal = {APMIS},
year = {2024},
volume = {132},
number = {7},
pages = {515--525},
doi = {10.1111/apm.13411}
}
EUVIMED